Increased platelet activation in patients with stable and acute exacerbation of COPD - Wikidata - awgldk - TriplyDB

Increased platelet activation in patients with stable and acute exacerbation of COPD

Increased platelet activation in patients with stable and acute exacerbation of COPD

http://www.wikidata.org/entity/Q58316988

about

COPD and stroke: are systemic inflammation and oxidative stress the missing links?Protocol for a human in vivo model of acute cigarette smoke inhalation challenge in smokers with COPD: monitoring the nasal and systemic immune response using a network biology approach Systemic effects of polymethylmethycrylate in total knee replacement: A prospective case-control study.The role of circulating serotonin in the development of chronic obstructive pulmonary disease.Increased platelet reactivity in idiopathic pulmonary fibrosis is mediated by a plasma factor Underdiagnosis and prognosis of chronic obstructive pulmonary disease after percutaneous coronary intervention: a prospective study.Elevated cardiovascular risk among adults with obstructive and restrictive airway functioning in the United States: a cross-sectional study of the National Health and Nutrition Examination Survey from 2007-2010.Stage-dependent association of BDNF and TGF-β1 with lung function in stable COPD.Target renal damage: the microvascular associations of increased aortic stiffness in patients with COPD.Adhesion molecules in subjects with COPD and healthy non-smokers: a cross sectional parallel group study.Pathophysiologic mechanisms of cardiovascular disease in obstructive sleep apnea syndrome Development and validation of a model to predict the risk of exacerbations in chronic obstructive pulmonary disease.Cardiovascular risk, myocardial injury, and exacerbations of chronic obstructive pulmonary disease.Relationship between metabolic syndrome and epicardial fat tissue thickness in patients with chronic obstructive pulmonary disease.Patent foramen ovale is not associated with hypoxemia in severe chronic obstructive pulmonary disease and does not impair exercise performance.Link between chronic obstructive pulmonary disease and coronary artery disease: implication for clinical practice.Vascular dysfunction in chronic obstructive pulmonary disease: current evidence and perspectives.Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease.Mechanisms of acute exacerbation of respiratory symptoms in chronic obstructive pulmonary disease.Platelet activation as a novel mechanism of atherothrombotic risk in chronic obstructive pulmonary disease.The role of microparticles in chronic obstructive pulmonary disease Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD.Management of Chronic Obstructive Pulmonary Disease in Patients with Cardiovascular Diseases.AIMAR survey on COPD phenotypes.The potential role of endothelial dysfunction and platelet activation in the development of thrombotic risk in COPD patients.One-year and long-term mortality in patients hospitalized for chronic obstructive pulmonary disease.Effects of cardiovascular drugs on mortality in severe chronic obstructive pulmonary disease.Mean platelet volume is decreased during an acute exacerbation of chronic obstructive pulmonary disease.A Longitudinal Cohort Study of Aspirin Use and Progression of Emphysema-like Lung Characteristics on CT Imaging: The MESA Lung Study.Association of thrombocytosis with COPD morbidity: the SPIROMICS and COPDGene cohorts.Impact of acute exacerbations on platelet reactivity in chronic obstructive pulmonary disease patients.Cigarette Smoke Increases Endothelial CXCL16-Leukocyte CXCR6 Adhesion In Vitro and In Vivo. Potential Consequences in Chronic Obstructive Pulmonary Disease.The association of aspirin use with severity of acute exacerbation of chronic obstructive pulmonary disease: a retrospective cohort study.Chronic obstructive pulmonary disease is just one component of the complex multimorbidities in patients with COPD.Thrombocytosis is associated with increased short and long term mortality after exacerbation of chronic obstructive pulmonary disease: a role for antiplatelet therapy?The involvement of serotonin metabolism in cigarette smoke-induced oxidative stress in rat lung in vivo.Increased platelet binding to circulating monocytes in idiopathic pulmonary fibrosis.Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: protocol of a randomised controlled proof-of-concept trial (APPLE COPD-ICON 2).Chronic Obstructive Pulmonary Disease and Cardiovascular Diseases: A “Vulnerable” Relationship

P2860

Q26746530-214FBEDB-DFE3-4329-BA4C-5A1FDFD3DBEE Q28650506-5388E242-2438-4AF7-B84A-0A85253B24C4 Q33676474-3E7F7179-210A-477B-A32E-76FF127C32BF Q34154873-98CECF1B-DDC4-4316-9133-87A7EC61711E Q34388484-1F2D48B9-D811-43FD-A442-D2C9D8333D61 Q35871744-2A5E630D-D099-4F82-9518-648DD4167C1C Q36539136-4DE0E076-AEB7-479A-B228-3522B61470DA Q36578484-835FCC14-201C-4650-A31E-D980EA9ECD9D Q36689652-9D6EE85D-13AF-48B8-B9F6-6DEB01AC07DE Q36891689-4811B810-9250-4FCF-B57F-07F7E9E34F28 Q37015491-6AA85672-42E3-44B9-B0E0-FFD86A1DE034 Q37232113-5F59CB94-87C1-4D0E-9B68-D90090850AF9 Q37393678-83AFE0D6-E9FB-43AF-B111-973266E035CA Q37672908-0B607B95-D391-4FE1-9D85-07A0EDCC3B96 Q37688485-FB1A30D6-DE80-488A-B582-B3834BA23023 Q37964807-EE9383F9-B3C4-4BCF-B4DA-C9F1C8619FF6 Q37979248-B686C0B8-EFAB-48FF-920C-63278ABB3149 Q38056532-39F83FD3-14C5-4345-BA49-6FCB27AE349D Q38089196-11FFE762-902F-41D6-A7FD-37F98FA9BD96 Q38132823-07BAD693-B7B3-41F3-B8FF-3796C5E72EC1 Q38202635-F8239362-E48F-4998-B20C-E086FB27FAE3 Q38621350-4F48B54D-8656-481E-B83A-86D37F740A5B Q38871993-FF708207-8185-47C1-BDA2-76F8BE9C65E2 Q38880954-7CC30C34-AFE1-4540-B244-A8C0E0AAD6E6 Q39426025-FEF5FC80-9DE4-419B-AD6D-2B7369B7A6A6 Q41841366-A27497BD-6B18-49F6-A5C5-289A2549AC06 Q43497078-B2B3AFEE-FB63-4304-8943-CAC4C44E0C85 Q44757661-08842E49-6A35-4B48-8009-F26809849956 Q47244932-7052B7FD-4601-41B0-AE9E-4959E52F1643 Q47646333-9B25214C-3493-4173-A6F5-7C90148F701F Q47654408-C3E66D89-A1D3-4B7E-8492-DAEA1AB47108 Q47720267-5D87ACA2-0954-4717-8561-807ECF1DCE2C Q50218743-96D78C46-0898-43C3-A8F3-F73EA9729664 Q50716312-8CAA5E20-61A3-4E49-8769-CE32A4D95B9B Q51729275-89763E3C-3872-4A50-93C8-77362F63CC3E Q52628759-0AC65E6C-AA89-4126-9DB6-8EEB155B74F4 Q53074465-E4337261-9241-4264-8D3F-0CDC6037FEA5 Q54949062-DDC37FF7-F3F1-4969-9C96-918D9D3106D5 Q58316978-7583AA0C-E526-469E-8E73-C8079AC0057D

P2860

Increased platelet activation in patients with stable and acute exacerbation of COPD

http://www.wikidata.org/entity/Q58316988

description

im April 2011 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 20 April 2011

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у квітні 2011

@uk

name

Increased platelet activation in patients with stable and acute exacerbation of COPD

@en

Increased platelet activation in patients with stable and acute exacerbation of COPD

@nl

type

label

Increased platelet activation in patients with stable and acute exacerbation of COPD

@en

Increased platelet activation in patients with stable and acute exacerbation of COPD

@nl

prefLabel

Increased platelet activation in patients with stable and acute exacerbation of COPD

@en

Increased platelet activation in patients with stable and acute exacerbation of COPD

@nl

P1433

Q58316988-570CB394-D845-4C6A-AAEF-DBA45FC406FD

P1476

Q58316988-C14FB8FA-4DCD-483D-AC58-657D9468FBF2

P2093

Q58316988-0D113730-983B-4B1A-BC24-CDA4BB426E30

Q58316988-22759140-5909-46D9-BD1D-8380894CC8BE

Q58316988-28BE6B4E-FE0A-42F5-90C9-BC5471FB942B

Q58316988-5BF5263F-FCF2-4529-A9C8-B22853D2812E

Q58316988-8C204CD0-E5D5-4BBF-9742-8071A1C6E871

Q58316988-984FE53C-DDE5-4754-B081-A9C29EE6DB33

Q58316988-FAC51654-4C79-46B6-B537-B813E9F89570

P304

Q58316988-C3FBE27A-978A-4E2F-926F-C739153C53B2

P31

Q58316988-FEB7EFE5-2614-4080-860C-3B21B3F9D225

P356

Q58316988-00AD4BEF-8EB9-454E-AC73-477D5F9552EB

P407

Q58316988-3D8D3081-8264-484D-ACA2-CF36F6F891BB

P433

Q58316988-AB89F863-334C-4A46-9B54-4848E397FB19

P478

Q58316988-554F8343-CE8E-40AC-9C3C-D083F166BF6C

P50

Q58316988-E5558B91-8100-4279-B26B-2D52E76A213D

Q58316988-F1925CDA-C017-431A-9DE9-5080B0D67180

P577

Q58316988-B5EB550E-B2E8-4187-9CAD-64B34F243473

P698

Q58316988-2EFAC1CE-E674-48DE-B8FB-7D34A0FA920A

P921

Q58316988-2E5CE273-623F-4D01-A1D4-BA55D0D36FA7

Q58316988-A32C2165-A5C1-4091-B9BC-B10AADE3B72D

P356

THX.2010.157529

P1433

P1476

Increased platelet activation in patients with stable and acute exacerbation of COPD

@en

P2093

Andrew Deans

http://www.w3.org/2001/XMLSchema#string

Catherine McGuinnes

http://www.w3.org/2001/XMLSchema#string

David A McAllister

http://www.w3.org/2001/XMLSchema#string

David E Newby

http://www.w3.org/2001/XMLSchema#string

Jennifer Raftis

http://www.w3.org/2001/XMLSchema#string

John D Maclay

http://www.w3.org/2001/XMLSchema#string

Shonna Johnston

http://www.w3.org/2001/XMLSchema#string

P304

769-774

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/THX.2010.157529

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P50

Nicholas L Mills

P577

2011-04-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21507906

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease